Gene ID | Gene array Fold Change | p value | PCR Fold Change | p value |
ADPN/PNPLA3 | −3.02 | <0.0001 | −1.64 | 0.0077 |
ANKRD33 | 2.29 | <0.0001 | 1.63 | 0.0264 |
DAAM2 | 2.45 | <0.0001 | 3.24 | <0.0001 |
EDN1 | 2.10 | <0.0001 | 1.19 | 0.3433 |
EPHX1 | −2.60 | <0.0001 | −1.69 | 0.0034 |
FABP4 | −3.18 | <0.0001 | −2.86 | <0.0001 |
IL18R1 | 2.28 | <0.0001 | 1.95 | 0.0055 |
IL1RL1 | 2.35 | <0.0001 | 1.89 | 0.0013 |
PRSS21 | −3.01 | <0.0001 | −1.91 | 0.0116 |
SCD | −2.90 | <0.0001 | −1.57 | 0.0105 |
TPST | 2.96 | <0.0001 | 1.92 | 0.0003 |
ZNF165 | 2.41 | <0.0001 | 1.37 | 0.0226 |
Severe COPD (GOLD 3/4) vs moderate COPD (GOLD 2) subjects for the nominated gene set. Positive fold change values indicate increase in GOLD stage 3/4 compared to GOLD stage 2.